BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6408014)

  • 1. Plasma concentration of cutaneously applied trinitroglycerin.
    Magometschnigg D; Horwatitsch H; Pichler M
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):178-82. PubMed ID: 6408014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dose and ointment application technique on nitroglycerin plasma concentrations.
    Iafrate RP; Yost RL; Curry SH; Gotz VP; Caranasos GJ
    Pharmacotherapy; 1983; 3(2 Pt 1):118-24. PubMed ID: 6406987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic levels of glyceryl trinitrate following topical application to the anoderm do not correlate with the measured reduction in anal pressure.
    Jonas M; Barrett DA; Shaw PN; Scholefield JH
    Br J Surg; 2001 Dec; 88(12):1613-6. PubMed ID: 11736974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of nitroglycerin ointments in the rabbit.
    Ritschel WA; Ritschel-Beurlin G; Grummich K
    Arzneimittelforschung; 1980; 30(3):432-5. PubMed ID: 6770874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS).
    Imhof PR; Vuillemin T; Gérardin A; Racine A; Müller P; Follath F
    Eur J Clin Pharmacol; 1984; 27(1):7-12. PubMed ID: 6436032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitroglycerin concentration in plasma: comparison between transdermal therapeutic system and ointment.
    Chu LC; Gale RM; Schmitt LG; Shaw JE
    Angiology; 1984 Sep; 35(9):545-52. PubMed ID: 6435484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the safety and efficacy of topical nitroglycerin ointment to facilitate venous cannulation.
    Griffith P; James B; Cropp A
    Nurs Res; 1994; 43(4):203-6. PubMed ID: 8047423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of nitroglycerin generated by three nitroglycerin patch preparations, Nitradisc, Transiderm-Nitro and Nitro-Dur and one ointment formulation, Nitrobid.
    McAllister A; Mosberg H; Settlage JA; Steiner JA
    Br J Clin Pharmacol; 1986 Apr; 21(4):365-9. PubMed ID: 3085698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and relative bioavailability of a nitroglycerin ointment formulation (author's transl)].
    Maier-Lenz H; Ringwelski L; Windorfer A
    Arzneimittelforschung; 1980; 30(2):320-4. PubMed ID: 6769443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous absorption of ibuprofen from different formulations. Comparative study with gel, hydrophilic ointment and emulsion cream.
    Seth PL
    Arzneimittelforschung; 1993 Aug; 43(8):919-21. PubMed ID: 8216453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eberconazole cream: topical and general tolerability, sensitisation potential, and systemic availability.
    Barbanoj MJ; Antonijoan R; García-Gea C; Puntes M; Gich I; Jané F
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):227-34. PubMed ID: 16082423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of various cutaneously administered nitroglycerin preparations on coronary heart disease].
    Zeiher A; Drexler H; Bonzel T; Wollschläger H; Hust MH; Löllgen H; Just H
    Schweiz Med Wochenschr Suppl; 1984; 16():70-6. PubMed ID: 6429852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 5th communication: factors affecting percutaneous absorption in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Okamura Y; Kashiwazaki K; Takahashi N
    Arzneimittelforschung; 1997 Mar; 47(3):270-5. PubMed ID: 9105545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bioavailability of glycerol trinitrate (nitroglycerin) from an ointment preparation].
    Gielsdorf W; Schlegel E; Settlage JA; Jaeger H; Fink E
    Arzneimittelforschung; 1983; 33(12):1677-9. PubMed ID: 6421295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and bioavailability of percutaneous ibuprofen.
    Kleinbloesem CH; Ouwerkerk M; Spitznagel W; Wilkinson FE; Kaiser RR
    Arzneimittelforschung; 1995 Oct; 45(10):1117-21. PubMed ID: 8595072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
    Królicki A
    Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative determination of trinitroglycerin in human plasma.
    Wei JY; Reid PR
    Circulation; 1979 Mar; 59(3):588-92. PubMed ID: 104804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro investigations of drug release and penetration--enhancing effect of ultrasound on transmembrane transport of flufenamic acid.
    Hippius M; Uhlemann C; Smolenski U; Schreiber U; Reissig S; Hoffmann A
    Int J Clin Pharmacol Ther; 1998 Feb; 36(2):107-11. PubMed ID: 9520159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased topical tacrolimus absorption in generalized leukemic erythroderma.
    Teshima D; Ikesue H; Itoh Y; Urabe K; Furue M; Oishi R
    Ann Pharmacother; 2003 Oct; 37(10):1444-7. PubMed ID: 14519034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in the rhesus monkey: estimate of percutaneous first-pass metabolism.
    Wester RC; Noonan PK; Smeach S; Kosobud L
    J Pharm Sci; 1983 Jul; 72(7):745-8. PubMed ID: 6411893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.